AVALO THERAPEUTICS, INC. Interest Income (Expense), Nonoperating, Net
AVALO THERAPEUTICS, INC. (AVTX) reported Interest Income (Expense), Nonoperating, Net of $2.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-06
- AVALO THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was $2.76M, a 151.69% increase year-over-year.
- AVALO THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was $803.00K, a 30.05% decline year-over-year.
- AVALO THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was $984.00K, a 18.74% decline year-over-year.
- AVALO THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $1.12M, a 15.87% increase year-over-year.
- AVALO THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2025 was $4.35M, a 31.37% increase from fiscal 2024.
- AVALO THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2024 was $3.31M.
- AVALO THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2023 was -$3.42M.
- AVALO THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2022 was -$4.17M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 3 month as first filed | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 6 month as first filed | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month | Interest Income (Expense), Nonoperating, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.76M 10-Q · filed 2026-08-06 | $3.56M 10-Q · filed 2026-08-06 | $4.55M derived: sum of 3 quarters · filed 2026-08-06 | $5.67M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $803.00K 10-Q · filed 2026-05-13 | $1.79M derived: sum of 2 quarters · filed 2026-05-13 | $2.90M derived: sum of 3 quarters · filed 2026-05-13 | $4.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $984.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $2.10M derived: sum of 2 quarters · filed 2026-03-23 | $3.20M derived: sum of 3 quarters · filed 2026-08-06 | $4.35M 10-K · filed 2026-03-23 | |||
| 2025-09-30 | $1.12M 10-Q · filed 2025-11-06 | $2.21M derived: sum of 2 quarters · filed 2026-08-06 | $3.37M 10-Q · filed 2025-11-06 | $4.57M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $1.10M 10-Q · filed 2026-08-06 | $1.10M 10-Q · filed 2025-08-07 | $2.24M 10-Q · filed 2026-08-06 | $2.25M 10-Q · filed 2025-08-07 | $3.46M derived: sum of 3 quarters · filed 2026-08-06 | $4.42M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $1.15M 10-Q · filed 2026-05-13 | $2.36M derived: sum of 2 quarters · filed 2026-05-13 | $3.32M derived: sum of 3 quarters · filed 2026-05-13 | $4.36M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $2.17M derived: sum of 2 quarters · filed 2026-03-23 | $3.21M derived: sum of 3 quarters · filed 2026-03-23 | $3.31M 10-K · filed 2026-03-23 | $3.32M 10-K · filed 2025-03-20 | ||
| 2024-09-30 | $964.00K 10-Q · filed 2025-11-06 | $2.00M derived: sum of 2 quarters · filed 2025-11-06 | $2.10M 10-Q · filed 2025-11-06 | $2.18M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $1.04M 10-Q · filed 2025-08-07 | $1.14M 10-Q · filed 2025-08-07 | $1.22M derived: sum of 3 quarters · filed 2025-08-07 | -$333.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-12 | $181.00K derived: sum of 2 quarters · filed 2025-05-12 | -$1.37M derived: sum of 3 quarters · filed 2025-05-12 | -$2.37M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$1.47M derived: sum of 2 quarters · filed 2025-03-20 | -$2.47M derived: sum of 3 quarters · filed 2025-03-20 | -$3.42M 10-K · filed 2025-03-20 | |||
| 2023-09-30 | -$1.55M 10-Q · filed 2024-11-07 | -$2.55M derived: sum of 2 quarters · filed 2024-11-07 | -$3.50M 10-Q · filed 2024-11-07 | -$4.45M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$996.00K 10-Q · filed 2024-08-12 | -$1.95M 10-Q · filed 2024-08-12 | -$2.89M derived: sum of 3 quarters · filed 2024-08-12 | -$3.79M derived: sum of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | -$949.00K 10-Q/A · filed 2024-07-11 | -$1.90M derived: sum of 2 quarters · filed 2024-07-11 | -$2.80M derived: sum of 3 quarters · filed 2024-07-11 | -$3.95M derived: sum of 4 quarters · filed 2024-07-11 | |||
| 2022-12-31 | -$949.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$1.85M derived: sum of 2 quarters · filed 2024-03-29 | -$3.00M derived: sum of 3 quarters · filed 2024-03-29 | -$4.17M 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$898.00K 10-Q · filed 2023-11-09 | -$2.05M derived: sum of 2 quarters · filed 2023-11-09 | -$3.22M 10-Q · filed 2023-11-09 | -$4.41M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$1.15M 10-Q · filed 2023-08-03 | -$2.32M 10-Q · filed 2023-08-03 | -$3.51M derived: sum of 3 quarters · filed 2023-08-03 | -$4.49M derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | -$1.17M 10-Q · filed 2023-05-04 | -$2.35M derived: sum of 2 quarters · filed 2023-05-04 | -$3.34M derived: sum of 3 quarters · filed 2023-05-04 | -$3.58M derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$2.17M derived: sum of 2 quarters · filed 2023-03-29 | -$2.41M derived: sum of 3 quarters · filed 2023-03-29 | -$2.39M 10-K · filed 2023-03-29 | |||
| 2021-09-30 | -$985.00K 10-Q · filed 2022-11-07 | -$1.22M derived: sum of 2 quarters · filed 2022-11-07 | -$1.21M 10-Q · filed 2022-11-07 | -$1.16M derived: sum of 4 quarters · filed 2022-11-07 | |||
| 2021-06-30 | -$239.00K 10-Q · filed 2022-08-04 | -$222.00K 10-Q · filed 2022-08-04 | -$173.00K derived: sum of 3 quarters · filed 2022-08-04 | -$173.00K derived: sum of 4 quarters · filed 2022-08-04 | |||
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-05 | $66.00K derived: sum of 2 quarters · filed 2022-05-05 | $66.00K derived: sum of 3 quarters · filed 2022-05-05 | $75.00K derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $49.00K derived: sum of 2 quarters · filed 2022-03-02 | $58.00K derived: sum of 3 quarters · filed 2022-03-02 | $49.00K 10-K · filed 2022-03-02 | $48.87K 10-K · filed 2021-03-08 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $9.00K derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $753.95K derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | $9.00K 10-Q · filed 2021-08-02 | $8.71K 10-Q · filed 2020-08-06 | $18.00K 10-Q · filed 2021-08-02 | $18.50K 10-Q · filed 2020-08-06 | $753.95K derived: sum of 3 quarters · filed 2021-08-02 | $548.01K derived: sum of 4 quarters · filed 2021-08-02 | |
| 2020-03-31 | $10.00K 10-Q · filed 2021-05-13 | $9.79K 10-Q · filed 2020-05-07 | $744.95K derived: sum of 2 quarters · filed 2021-05-13 | $539.01K derived: sum of 3 quarters · filed 2021-05-13 | $577.42K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $734.95K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $529.01K derived: sum of 2 quarters · filed 2021-03-08 | $567.42K derived: sum of 3 quarters · filed 2021-03-08 | $121.33K 10-K · filed 2021-03-08 | |||
| 2019-09-30 | -$205.94K 10-Q · filed 2019-11-14 | -$167.53K derived: sum of 2 quarters · filed 2020-08-06 | -$613.62K 10-Q · filed 2019-11-14 | $456.62K derived: sum of 4 quarters · filed 2020-08-06 | |||
| 2019-06-30 | $38.41K 10-Q · filed 2020-08-06 | -$199.75K 10-Q · filed 2019-08-08 | $68.63K 10-Q · filed 2020-08-06 | -$407.69K 10-Q · filed 2019-08-08 | $662.55K derived: sum of 3 quarters · filed 2020-08-06 | $427.70K derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $30.22K 10-Q · filed 2020-05-07 | -$207.94K 10-Q · filed 2019-05-09 | $624.14K derived: sum of 2 quarters · filed 2020-05-07 | $389.29K derived: sum of 3 quarters · filed 2020-05-07 | $146.88K derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2018-12-31 | $593.92K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $359.07K derived: sum of 2 quarters · filed 2020-03-11 | $116.66K derived: sum of 3 quarters · filed 2020-03-11 | $16.26K 10-K · filed 2020-03-11 | -$811.62K 10-K · filed 2019-03-18 | ||
| 2018-09-30 | -$234.85K 10-Q · filed 2019-11-14 | -$477.26K derived: sum of 2 quarters · filed 2019-11-14 | -$577.66K 10-Q · filed 2019-11-14 | -$546.66K derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | -$242.41K 10-Q · filed 2019-08-08 | -$342.81K 10-Q · filed 2019-08-08 | -$311.81K derived: sum of 3 quarters · filed 2019-08-08 | -$282.42K derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | -$100.40K 10-Q · filed 2019-05-09 | -$69.40K derived: sum of 2 quarters · filed 2019-05-09 | -$40.02K derived: sum of 3 quarters · filed 2019-05-09 | -$65.65K derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $31.00K 10-K · filed 2018-04-02 | $60.39K derived: sum of 2 quarters · filed 2018-11-13 | $34.76K derived: sum of 3 quarters · filed 2018-11-13 | -$24.02K 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $29.39K 10-Q · filed 2018-11-13 | $3.76K derived: sum of 2 quarters · filed 2018-11-13 | -$53.99K 10-Q · filed 2018-11-13 | -$136.99K derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | -$25.63K 10-Q · filed 2018-08-09 | -$83.38K 10-Q · filed 2018-08-09 | -$166.38K derived: sum of 3 quarters · filed 2018-08-09 | -$270.38K derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | -$57.75K 10-Q · filed 2018-05-11 | -$140.75K derived: sum of 2 quarters · filed 2018-05-11 | -$244.75K derived: sum of 3 quarters · filed 2018-05-11 | -$371.75K derived: sum of 4 quarters · filed 2018-05-11 | |||
| 2016-12-31 | -$83.00K 10-K · filed 2018-04-02 | -$187.00K derived: sum of 2 quarters · filed 2018-04-02 | -$314.00K derived: sum of 3 quarters · filed 2018-04-02 | -$464.18K 10-K · filed 2018-04-02 | |||
| 2016-09-30 | -$104.00K 10-K · filed 2018-04-02 | -$104.18K 10-Q · filed 2016-11-08 | -$231.00K derived: sum of 2 quarters · filed 2018-04-02 | -$381.60K 10-Q · filed 2017-11-07 | -$540.00K derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2016-06-30 | -$127.00K 10-K · filed 2018-04-02 | -$126.88K 10-Q · filed 2016-08-15 | -$277.42K 10-Q · filed 2017-08-14 | -$436.00K derived: sum of 3 quarters · filed 2018-04-02 | -$633.00K derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2016-03-31 | -$151.00K 10-K · filed 2018-04-02 | -$150.54K 10-Q · filed 2016-05-16 | -$309.00K derived: sum of 2 quarters · filed 2018-04-02 | -$506.00K derived: sum of 3 quarters · filed 2018-04-02 | -$725.00K derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2015-12-31 | -$158.00K 10-K · filed 2017-03-14 | -$355.00K derived: sum of 2 quarters · filed 2017-03-14 | -$574.00K derived: sum of 3 quarters · filed 2017-03-14 | -$793.21K 10-K · filed 2018-04-02 | |||
| 2015-09-30 | -$197.00K 10-K · filed 2017-03-14 | -$416.00K derived: sum of 2 quarters · filed 2017-03-14 | -$634.77K 10-Q · filed 2016-11-08 | -$856.00K derived: sum of 4 quarters · filed 2017-03-14 | |||
| 2015-06-30 | -$219.00K 10-K · filed 2017-03-14 | -$437.30K 10-Q · filed 2016-08-15 | -$659.00K derived: sum of 3 quarters · filed 2017-03-14 | -$849.00K derived: sum of 4 quarters · filed 2017-03-14 | |||
| 2015-03-31 | -$219.00K 10-K · filed 2017-03-14 | -$440.00K derived: sum of 2 quarters · filed 2017-03-14 | -$630.00K derived: sum of 3 quarters · filed 2017-03-14 | -$1.43M derived: sum of 4 quarters · filed 2017-03-14 | |||
| 2014-12-31 | -$221.00K 10-K · filed 2016-03-23 | -$411.00K derived: sum of 2 quarters · filed 2016-03-23 | -$1.21M derived: sum of 3 quarters · filed 2016-03-23 | -$1.21M 10-K · filed 2017-03-14 | |||
| 2014-09-30 | -$190.00K 10-K · filed 2016-03-23 | -$985.00K derived: sum of 2 quarters · filed 2016-03-23 | -$985.00K derived: sum of 3 quarters · filed 2016-03-23 | ||||
| 2014-06-30 | -$795.00K 10-K · filed 2016-03-23 | -$795.00K derived: sum of 2 quarters · filed 2016-03-23 | |||||
| 2014-03-31 | $0.00 10-K · filed 2016-03-23 | ||||||
| 2013-12-31 | $10.55K 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |